Compare Humana Inc (HUM) vs Sibanye Stillwater Ltd (SBSW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Sibanye Stillwater Ltd — how do they compare? Humana Inc trades at $442 (market cap $47.61B), while Sibanye Stillwater Ltd trades at $10.12 (market cap $6.89B). The key difference: Humana Inc is far larger — about 6.9× Sibanye Stillwater Ltd's market cap, and Sibanye Stillwater Ltd pays the higher dividend (8.36%). Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and Sibanye Stillwater Ltd for 51 Days on average.
| HUM | SBSW | |
|---|---|---|
Market Cap | $47.61B | $6.89B |
Volume | 1,827,332 | 5,024,779 |
Sector | Health | Basic Materials |
52-Week High | $409.85 | $21.12 |
52-Week Low | $163.67 | $8.00 |
Typical Hold Time | 53 Days | 51 Days |
Enterprise Value | $54.97B | $7.79B |
Dividend Yield | 0.89% | 8.36% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $387.12, down 4.24% today, but maintains a bullish technical outlook with strong institutional support. The stock shows mixed fundamentals with revenue growth to $129.66B in 2025 but declining profit margins at 0.88%. Recent analyst upgrades, including Barclays' $515 target on September 25, 2026, highlight optimism despite ongoing Medicare Advantage plan adjustments affecting member transitions.
Investment outlook remains cautiously optimistic with a consensus price target of $432.63 offering 12% upside. Risks include margin compression, regulatory scrutiny from Medicare billing practices, and competitive pressures in managed care. The company's strong cash position of $20.44B and consistent dividend payments provide stability amid enrollment volatility.
SBSW trades at $9.68, down 3.3% today, with a bearish technical outlook. The company shows mixed fundamentals with strong valuation ratios (P/E 7.98, P/S 0.69) but negative net income of -$5.17B in 2025. Recent Q2 2026 earnings beat expectations with EPS of $1.34 versus $1.26 forecast. Operating cash flow improved significantly to $21.41B in 2025, while analyst consensus is bullish with a $14.25 price target.
The outlook suggests potential upside based on valuation and analyst targets, but risks include persistent negative earnings, high debt levels, and commodity price volatility. Investor sentiment is cautiously optimistic following strong H1 2026 results and institutional buying activity.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Sibanye Stillwater Ltd
Sibanye Stillwater Ltd is a South Africa-focused mining company. The Group currently owns and operates five underground and surface gold operations in South Africa: the Cooke, DRDGOLD, Driefontein, and Kloof operations in the West Witwatersrand region, and the Beatrix Operation in the southern Free State province. In addition to mining, the company owns and manages extraction and processing facilities at its operations, where gold-bearing ore is treated and beneficiated to produce gold dore. The gold dore is further refined at Rand Refinery into gold bars with a purity of at least 99.5% and is then sold on international markets. Sibanye holds a 44% interest in Rand Refinery, global refiners of gold, and the largest in Africa. Rand Refinery markets gold to customers around the world.
Read more on SBSW →
